These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 32329497)

  • 1. Ru(II)-Naphthoquinone complexes with high selectivity for triple-negative breast cancer.
    Oliveira KM; Peterson EJ; Carroccia MC; Cominetti MR; Deflon VM; Farrell NP; Batista AA; Correa RS
    Dalton Trans; 2020 Nov; 49(45):16193-16203. PubMed ID: 32329497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lapachol in the Design of a New Ruthenium(II)-Diphosphine Complex as a Promising Anticancer Metallodrug.
    Oliveira KM; Honorato J; Demidoff FC; Schultz MS; Netto CD; Cominetti MR; Correa RS; Batista AA
    J Inorg Biochem; 2021 Jan; 214():111289. PubMed ID: 33137682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxicity and anti-tumor effects of new ruthenium complexes on triple negative breast cancer cells.
    Popolin CP; Reis JPB; Becceneri AB; Graminha AE; Almeida MAP; Corrêa RS; Colina-Vegas LA; Ellena J; Batista AA; Cominetti MR
    PLoS One; 2017; 12(9):e0183275. PubMed ID: 28898246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel ruthenium(ii) gallic acid complex disrupts the actin cytoskeleton and inhibits migration, invasion and adhesion of triple negative breast tumor cells.
    Graminha AE; Honorato J; Correa RS; Cominetti MR; Menezes ACS; Batista AA
    Dalton Trans; 2021 Jan; 50(1):323-335. PubMed ID: 33305766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New ruthenium complexes containing salicylic acid and derivatives induce triple-negative tumor cell death via the intrinsic apoptotic pathway.
    Graminha AE; Popolin C; Honorato de Araujo-Neto J; Correa RS; de Oliveira KM; Godoy LR; Vegas LC; Ellena J; Batista AA; Cominetti MR
    Eur J Med Chem; 2022 Dec; 243():114772. PubMed ID: 36191406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the Cytotoxicity of Chiral Ruthenium Complexes Containing Sulfur Amino Acids against Breast Tumor Cells (MDA-231 and MCF-7).
    Leite CM; de Araujo-Neto JH; Corrêa RS; Colina-Vegas L; Martínez-Otero D; Martins PR; Silva CG; Batista AA
    Anticancer Agents Med Chem; 2021; 21(9):1172-1182. PubMed ID: 32838726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiparasitic activities of novel ruthenium/lapachol complexes.
    Barbosa MI; Corrêa RS; de Oliveira KM; Rodrigues C; Ellena J; Nascimento OR; Rocha VP; Nonato FR; Macedo TS; Barbosa-Filho JM; Soares MB; Batista AA
    J Inorg Biochem; 2014 Jul; 136():33-9. PubMed ID: 24727183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cis-[RuCl(BzCN)(N-N)(P-P)]PF6 complexes: Synthesis and in vitro antitumor activity: (BzCN=benzonitrile; N-N=2,2'-bipyridine; 1,10-phenanthroline; P-P=1,4-bis(diphenylphosphino) butane, 1,2-bis(diphenylphosphino)ethane, or 1,1'-(diphenylphosphino)ferrocene).
    Pereira Fde C; Lima BA; de Lima AP; Pires WC; Monteiro T; Magalhães LF; Costa W; Graminha AE; Batista AA; Ellena J; Siveira-Lacerda Ede P
    J Inorg Biochem; 2015 Aug; 149():91-101. PubMed ID: 25873134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterobimetallic Ru(ii)/Fe(ii) complexes as potent anticancer agents against breast cancer cells, inducing apoptosis through multiple targets.
    Guedes APM; Mello-Andrade F; Pires WC; de Sousa MAM; da Silva PFF; de Camargo MS; Gemeiner H; Amauri MA; Gomes Cardoso C; de Melo Reis PR; Silveira-Lacerda EP; Batista AA
    Metallomics; 2020 Apr; 12(4):547-561. PubMed ID: 32108850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Ru(II)-bipyridine/phenanthroline-lapachol complexes as potential anti-cancer agents.
    De Grandis RA; Costa AR; Moraes CAF; Sampaio NZ; Cerqueira IH; Marques WG; Guedes APM; de Araujo-Neto JH; Pavan FR; Demidoff FC; Netto CD; Batista AA; Resende FA
    J Inorg Biochem; 2022 Dec; 237():112005. PubMed ID: 36155170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic activity of Ru(II)/DPEPhos/N,S-mercapto complexes (DPEPhos = bis-[(2-diphenylphosphino)phenyl]ether).
    Grawe GF; Oliveira KM; Leite CM; de Oliveira TD; Costa AR; Moraes CAF; Honorato J; Cominetti MR; Castellano EE; Correa RS; Machado SP; Batista AA
    J Inorg Biochem; 2023 Jul; 244():112204. PubMed ID: 37004320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The trans-[Ru(PPh
    Becceneri AB; Popolin CP; Plutin AM; Maistro EL; Castellano EE; Batista AA; Cominetti MR
    J Inorg Biochem; 2018 Sep; 186():70-84. PubMed ID: 29857173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ru(II)/diclofenac-based complexes: DNA, BSA interaction and their anticancer evaluation against lung and breast tumor cells.
    Oliveira KM; Honorato J; Gonçalves GR; Cominetti MR; Batista AA; Correa RS
    Dalton Trans; 2020 Sep; 49(36):12643-12652. PubMed ID: 32870224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ru(II)/clotrimazole/diphenylphosphine/bipyridine complexes: Interaction with DNA, BSA and biological potential against tumor cell lines and Mycobacterium tuberculosis.
    Colina-Vegas L; Dutra JL; Villarreal W; de A Neto JH; Cominetti MR; Pavan F; Navarro M; Batista AA
    J Inorg Biochem; 2016 Sep; 162():135-145. PubMed ID: 27383651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel lawsone-containing ruthenium(II) complexes: Synthesis, characterization and anticancer activity on 2D and 3D spheroid models of prostate cancer cells.
    De Grandis RA; Santos PWDSD; Oliveira KM; Machado ART; Aissa AF; Batista AA; Antunes LMG; Pavan FR
    Bioorg Chem; 2019 Apr; 85():455-468. PubMed ID: 30776556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the biological potential of ruthenium(II) complexes with cinnamic acid.
    Graminha AE; Honorato J; Dulcey LL; Godoy LR; Barbosa MF; Cominetti MR; Menezes AC; Batista AA
    J Inorg Biochem; 2020 May; 206():111021. PubMed ID: 32163810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxicity of ruthenium-N,N-disubstituted-N'-acylthioureas complexes.
    de Oliveira TD; Plutín AM; Luna-Dulcey L; Castellano EE; Cominetti MR; Batista AA
    Mater Sci Eng C Mater Biol Appl; 2020 Oct; 115():111106. PubMed ID: 32600709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the potential of ruthenium(II)-phosphine-mercapto complexes as new anticancer agents.
    Palmeira-Mello MV; Costa AR; de Oliveira LP; Blacque O; Gasser G; Batista AA
    Dalton Trans; 2024 Jul; 53(26):10947-10960. PubMed ID: 38895770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Half-sandwich Os(ii) and Ru(ii) bathophenanthroline complexes: anticancer drug candidates with unusual potency and a cellular activity profile in highly invasive triple-negative breast cancer cells.
    Pracharova J; Novohradsky V; Kostrhunova H; Štarha P; Trávníček Z; Kasparkova J; Brabec V
    Dalton Trans; 2018 Sep; 47(35):12197-12208. PubMed ID: 30112527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pd(II)/diphosphine/curcumin complexes as potential anticancer agents.
    Dutra JL; Honorato J; Graminha A; Moraes CAF; de Oliveira KT; Cominetti MR; Castellano EE; Batista AA
    Dalton Trans; 2024 Dec; 53(47):18902-18916. PubMed ID: 38938129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.